M. LANGLOIS

714 total citations
34 papers, 600 citations indexed

About

M. LANGLOIS is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, M. LANGLOIS has authored 34 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 10 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in M. LANGLOIS's work include Analytical Methods in Pharmaceuticals (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Analytical Chemistry and Chromatography (5 papers). M. LANGLOIS is often cited by papers focused on Analytical Methods in Pharmaceuticals (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Analytical Chemistry and Chromatography (5 papers). M. LANGLOIS collaborates with scholars based in France, United Kingdom and Switzerland. M. LANGLOIS's co-authors include J. P. Dubost, Jean Grellet, Marie‐Claude Saux, Sames Sicsic, Shensi Shen, Alain M. Gardier, C. Boyer, Karen Gaudin, Catherine Belzung and Frank Lezoualc’h and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Chromatography A and British Journal of Pharmacology.

In The Last Decade

M. LANGLOIS

34 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. LANGLOIS France 14 185 160 147 118 108 34 600
Slavica Filipić Serbia 12 196 1.1× 211 1.3× 178 1.2× 87 0.7× 57 0.5× 30 561
Jacobus J. Bergh South Africa 19 229 1.2× 250 1.6× 429 2.9× 52 0.4× 99 0.9× 37 921
Yuqiang Wang China 20 384 2.1× 153 1.0× 173 1.2× 106 0.9× 92 0.9× 62 1.0k
Károly Mazák Hungary 14 149 0.8× 51 0.3× 96 0.7× 134 1.1× 41 0.4× 33 396
Milena Rizzo Italy 16 196 1.1× 45 0.3× 151 1.0× 67 0.6× 173 1.6× 32 684
Efraim Shek United States 14 114 0.6× 108 0.7× 96 0.7× 47 0.4× 40 0.4× 25 459
William C. Vincek United States 12 181 1.0× 77 0.5× 89 0.6× 74 0.6× 66 0.6× 24 416
Zheng Xia China 19 431 2.3× 205 1.3× 99 0.7× 112 0.9× 46 0.4× 37 1.1k
Massoud Mahmoudian Iran 17 575 3.1× 281 1.8× 296 2.0× 32 0.3× 99 0.9× 56 1.2k

Countries citing papers authored by M. LANGLOIS

Since Specialization
Citations

This map shows the geographic impact of M. LANGLOIS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. LANGLOIS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. LANGLOIS more than expected).

Fields of papers citing papers by M. LANGLOIS

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. LANGLOIS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. LANGLOIS. The network helps show where M. LANGLOIS may publish in the future.

Co-authorship network of co-authors of M. LANGLOIS

This figure shows the co-authorship network connecting the top 25 collaborators of M. LANGLOIS. A scholar is included among the top collaborators of M. LANGLOIS based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. LANGLOIS. M. LANGLOIS is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaubert, Alexandra, M. LANGLOIS, Mathieu Marchivie, et al.. (2022). Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria. Pharmaceutics. 14(2). 299–299. 3 indexed citations
2.
Kauss, Tina, M. LANGLOIS, Xiao Xie, et al.. (2019). Development of Rectodispersible Tablets and Granulate Capsules for the Treatment of Serious Neonatal Sepsis in Developing Countries. Journal of Pharmaceutical Sciences. 108(8). 2805–2813. 4 indexed citations
3.
Kauss, Tina, Mathieu Marchivie, Alexandra Gaubert, et al.. (2017). Preformulation studies of ceftriaxone for pediatric non-parenteral administration as an alternative to existing injectable formulations. European Journal of Pharmaceutical Sciences. 104. 382–392. 8 indexed citations
4.
Kauss, Tina, Alexandra Gaubert, Giovanni Tonelli, et al.. (2017). Development of rectal self-emulsifying suspension of a moisture-labile water-soluble drug. International Journal of Pharmaceutics. 536(1). 283–291. 20 indexed citations
5.
LANGLOIS, M., Elodie Mordelet, Pierre‐Olivier Couraud, et al.. (2015). Development of a solvent-free analytical method for paracetamol quantitative determination in Blood Brain Barrier in vitro model. Journal of Chromatography B. 988. 20–24. 14 indexed citations
6.
Devers, Séverine, Sames Sicsic, M. LANGLOIS, et al.. (2007). Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice. Behavioural Brain Research. 187(2). 455–461. 60 indexed citations
7.
Gaudin, Karen, A. Barbaud, C. Boyer, et al.. (2007). In vitro release and stability of an artesunate rectal gel suitable for pediatric use. International Journal of Pharmaceutics. 353(1-2). 1–7. 13 indexed citations
8.
Lezoualc’h, Frank, Ilse Dewachter, Claudine Deloménie, et al.. (2007). 5‐HT4 receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice. British Journal of Pharmacology. 150(7). 883–892. 58 indexed citations
9.
Gaudin, Karen, et al.. (2006). Stability of artesunate in pharmaceutical solvents. Journal of Pharmaceutical and Biomedical Analysis. 43(3). 1019–1024. 14 indexed citations
10.
LANGLOIS, M., et al.. (2004). Protonation equilibrium and lipophilicity of moxifloxacin. Journal of Pharmaceutical and Biomedical Analysis. 37(2). 389–393. 90 indexed citations
11.
Boyer, C., et al.. (2003). Simultaneous Determination of Irbesartan and Hydrochlorothiazide in Tablets by Derivative Spectrophotometry. Analytical Letters. 36(11). 2485–2495. 33 indexed citations
12.
Matoga, Myriam, et al.. (2002). Determination of pKa values of 2-amino-2-oxazolines by capillary electrophoresis. Journal of Chromatography A. 984(2). 253–260. 32 indexed citations
13.
Mathé‐Allainmat, Monique, et al.. (1998). Synthesis of benzocycloalkane derivatives as new conformationally restricted ligands for melatonin receptors. Bioorganic & Medicinal Chemistry Letters. 8(23). 3325–3330. 14 indexed citations
14.
LANGLOIS, M., et al.. (1994). Determination of a PAF antagonist pharmacophore using combined Molecular Electrostatic Potential and Molecular Lipophilicity Potential.. PubMed. 12(2). 149–67. 4 indexed citations
15.
LANGLOIS, M., et al.. (1994). Synthesis of quinazoline-2,4-dione and naphthalimide derivatives as new 5-HT3 receptor antagonists. European Journal of Medicinal Chemistry. 29(12). 925–940. 15 indexed citations
16.
LANGLOIS, M., et al.. (1994). Synthesis of symmetrical pseudopeptides as potential inhibitors of the human immunodeficiency virus-1 protease. European Journal of Medicinal Chemistry. 29(9). 639–647. 10 indexed citations
17.
LANGLOIS, M., et al.. (1993). Synthesis of new derivatives of 8-OH-DPAT: Influence of substitution on the aromatic ring on the pharmacological profile. Bioorganic & Medicinal Chemistry Letters. 3(10). 2035–2038. 2 indexed citations
18.
LANGLOIS, M., et al.. (1990). Lipophilicity force field profile: An expressive visualization of the lipophilicity molecular potential gradient. Journal of Molecular Graphics. 8(3). 153–155. 32 indexed citations
19.
Imbert, Thierry, et al.. (1984). Studies on the neuroleptic benzamides. III: Synthesis and antidopaminergic properties of new 3-nortropane derivatives. 19(2). 105–110. 6 indexed citations
20.
LANGLOIS, M., et al.. (1971). Recherches dans la serie des aryl-3 pyrrolidines—II. Tetrahedron. 27(22). 5641–5652. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Slavica Filipić Breakdown of academic impact, for papers by Jacobus J. Bergh Breakdown of academic impact, for papers by Yuqiang Wang Breakdown of academic impact, for papers by Károly Mazák Breakdown of academic impact, for papers by Milena Rizzo Breakdown of academic impact, for papers by Efraim Shek Breakdown of academic impact, for papers by William C. Vincek Breakdown of academic impact, for papers by Zheng Xia Breakdown of academic impact, for papers by Massoud Mahmoudian
Rankless by CCL
2026